C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 498/18 (2006.01) A61K 31/553 (2006.01) A61P 25/28 (2006.01) G01N 33/68 (2006.01) G01N 33/543 (2006.01)
Patent
CA 2568213
The present invention refers to the use of a specific indolocarbazole compound of general formula (1) or a pharmaceutically-acceptable a salt thereof for the preparation of a pharmaceutical composition for the prevention or treatment of a neurodegenerative and/or dementing illness driven by the molecular pathology of microtubule-associate tau such as Alzheimer's disease, frontal lobe dementia, Pick's disease, Parkinson disease with dementia, corticobasal degeneration, argyrophilic grains disease, or supranuclear palsy. A method for treating or preventing such illnesses is also disclosed. Furthermore, methods for the identification of efficacious inhibitors of neurofibrillary degeneration, and methods for the determination of an appropriate dosage of an inhibitor of the PHF-type tau hyperphosphorylation for the treatment of a condition characterized by neurofibrillary pathology are described.
L'invention concerne l'utilisation d'un composé d'indolocarbazole spécifique, de formule générale (1) ou d'un sel pharmaceutiquement acceptable de celui-ci, pour la préparation d'une composition pharmaceutique destinée à la prévention ou au traitement de maladies neurodégénérescentes et/ou de démences provoquées par la pathologie moléculaire de tau associé à des microtubules, telles que maladie d'Alzheimer, démence du lobe frontal, maladie de Pick, maladie de Parkinson avec démence, dégénérescence corticobasale, argyrophilie granulaire, ou paralysie supranucléaire. L'invention concerne en outre un procédé de traitement ou de prévention de telles maladies. Par ailleurs, l'invention concerne des procédés d'identification d'inhibiteurs efficaces de dégénérescence neurofibrillaire, ainsi que des procédés de détermination d'un dosage approprié d'un inhibiteur d'hyperphosphorylation de tau du type PHF, pour le traitement d'un état caractérisé par une pathologie neurofibrillaire.
Borden Ladner Gervais Llp
Tautatis Inc.
LandOfFree
Composition and method for the treatment of tauopathies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for the treatment of tauopathies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for the treatment of tauopathies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1681516